We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clinical meaning of sarcopenia in patients undergoing endoscopic treatment.
- Authors
Hiroyuki Hisada; Yosuke Tsuji; Hikaru Kuribara; Ryohei Miyata; Kaori Oshio; Satoru Mizutani; Hideki Nakagawa; Rina Cho; Nobuyuki Sakuma; Yuko Miura; Hiroya Mizutani; Daisuke Ohki; Seiichi Yakabi; Yu Takahashi; Yoshiki Sakaguchi; Naomi Kakushima; Nobutake Yamamichi; Mitsuhiro Fujishiro
- Abstract
With increasing global life expectancy, the significance of geriatric assessment parameters has increased. Sarcopenia is a crucial assessment parameter and is defined as the age-related loss of muscle mass and strength. Sarcopenia is widely acknowledged as a risk factor for postoperative complications in diverse advanced malignancies and has a detrimental effect on the long-term prognosis. While most studies have primarily concentrated on the correlation between sarcopenia and advanced cancer, more recent investigations have focused on the relationship between sarcopenia and early-stage cancer. Endoscopic submucosal dissection (ESD), which is less invasive than surgical intervention, is extensively employed in the management of early-stage cancer, although it is associated with complications such as bleeding and perforation. In recent years, several reports have revealed the adverse consequences of sarcopenia in patients with early-stage cancer undergoing ESD. This literature review briefly summarizes the recent studies on the association between sarcopenia and ESD.
- Subjects
LITERATURE reviews; PREOPERATIVE risk factors; MUSCLE mass; SARCOPENIA; GERIATRIC assessment
- Publication
Clinical Endoscopy, 2024, Vol 57, Issue 4, p446
- ISSN
2234-2400
- Publication type
Article
- DOI
10.5946/ce.2023.193